Generation Accumulated Other Comprehensive Income from 2010 to 2024
| GBIO Stock | USD 1.16 0.03 2.52% |
Accumulated Other Comprehensive Income | First Reported 2010-12-31 | Previous Quarter 274 K | Current Value 287.7 K | Quarterly Volatility 29.9 M |
Check Generation Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Generation Bio's main balance sheet or income statement drivers, such as Net Interest Income of 12.5 M, Interest Income of 12.5 M or Depreciation And Amortization of 3.8 M, as well as many indicators such as Price To Sales Ratio of 19.69, Dividend Yield of 0.0 or PTB Ratio of 0.55. Generation financial statements analysis is a perfect complement when working with Generation Bio Valuation or Volatility modules.
Generation | Accumulated Other Comprehensive Income |
Latest Generation Bio's Accumulated Other Comprehensive Income Growth Pattern
Below is the plot of the Accumulated Other Comprehensive Income of Generation Bio Co over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. Generation Bio's Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Generation Bio's overall financial position and show how it may be relating to other accounts over time.
| Accumulated Other Comprehensive Income | 10 Years Trend |
|
Accumulated Other Comprehensive Income |
| Timeline |
Generation Accumulated Other Comprehensive Income Regression Statistics
| Arithmetic Mean | (7,684,620) | |
| Geometric Mean | 35,976 | |
| Coefficient Of Variation | (388.47) | |
| Mean Deviation | 14,387,784 | |
| Median | (9,000) | |
| Standard Deviation | 29,852,152 | |
| Sample Variance | 891.2T | |
| Range | 115.9M | |
| R-Value | (0.12) | |
| Mean Square Error | 945.4T | |
| R-Squared | 0.01 | |
| Significance | 0.66 | |
| Slope | (814,304) | |
| Total Sum of Squares | 12476.1T |
Generation Accumulated Other Comprehensive Income History
About Generation Bio Financial Statements
Generation Bio investors utilize fundamental indicators, such as Accumulated Other Comprehensive Income, to predict how Generation Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 274 K | 287.7 K |
Pair Trading with Generation Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Generation Stock
Moving against Generation Stock
| 0.85 | BMY | Bristol Myers Squibb | PairCorr |
| 0.79 | ESPR | Esperion Therapeutics | PairCorr |
| 0.78 | DYAI | Dyadic International | PairCorr |
| 0.65 | GILD | Gilead Sciences | PairCorr |
| 0.4 | DNA | Ginkgo Bioworks Holdings Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.
The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Generation Bio Correlation against competitors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 0.28 | Quarterly Revenue Growth 2.52 | Return On Assets (0.19) | Return On Equity (0.86) |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.